Q: Which vendors sell Cerebrolysin with independent COA testing?

4 vendors in the Merit Verified directory have independent COA evidence on file for Cerebrolysin — 6 COAs total. COA coverage and test dates are listed on the Cerebrolysin page at https://meritverified.org/peptides/cerebrolysin.

Q: How do I verify the quality of Cerebrolysin from a vendor?

To verify Cerebrolysin quality, look for an independent certificate of analysis (COA) from a third-party lab — not a lab the vendor owns or pays directly. The COA should state the tested compound, lot number, purity percentage (identity and concentration), and the lab's name. Cross-reference the lot number against the vendor's current stock. Merit Verified indexes COAs for Cerebrolysin at https://meritverified.org/peptides/cerebrolysin so you can compare evidence across vendors before buying.

Q: What is the regulatory status of Cerebrolysin?

Cerebrolysin is tracked in the Merit Verified registry. Regulatory status for research peptides in the US has been evolving — the FDA has reclassified a number of peptides out of the 503A compounding ingredient list since 2025. Merit Verified does not provide legal or regulatory advice; check official FDA sources or consult a licensed professional for the current status of Cerebrolysin in your jurisdiction.

Question 1

What is Cerebrolysin?

Accepted Answer

Cerebrolysin is not a single peptide but a complex biologic produced by enzymatic hydrolysis of purified porcine brain tissue, containing low-molecular-weight peptides (<10 kDa) and free amino acids. Manufactured by EVER Pharma (Austria), it is registered in 50+ countries (Europe, Asia, Russia, Latin America) for ischemic stroke, traumatic brain injury, and dementia, but is NOT FDA-approved in the United States. Merit Verified tracks independent COA test results for Cerebrolysin from multiple vendors.

Question 2

Which vendors sell Cerebrolysin with independent COA testing?

Accepted Answer

4 vendors in the Merit Verified directory have independent COA evidence on file for Cerebrolysin — 6 COAs total. COA coverage and test dates are listed on the Cerebrolysin page at https://meritverified.org/peptides/cerebrolysin.

Question 3

How do I verify the quality of Cerebrolysin from a vendor?

Accepted Answer

To verify Cerebrolysin quality, look for an independent certificate of analysis (COA) from a third-party lab — not a lab the vendor owns or pays directly. The COA should state the tested compound, lot number, purity percentage (identity and concentration), and the lab's name. Cross-reference the lot number against the vendor's current stock. Merit Verified indexes COAs for Cerebrolysin at https://meritverified.org/peptides/cerebrolysin so you can compare evidence across vendors before buying.

Question 4

What is the regulatory status of Cerebrolysin?

Accepted Answer

Cerebrolysin is tracked in the Merit Verified registry. Regulatory status for research peptides in the US has been evolving — the FDA has reclassified a number of peptides out of the 503A compounding ingredient list since 2025. Merit Verified does not provide legal or regulatory advice; check official FDA sources or consult a licensed professional for the current status of Cerebrolysin in your jurisdiction.

	Vendor	Price	$/mg	vs avg	Purity	COAs	Merit
🇺🇸	Profound Aminos via Disclosed Labs · 1h ago	$46.00· 60mg	$0.77/mg	-28.5%	—	—	95	Buy
🇺🇸	Certified Peptides ✓ verified at source · 1h ago	$110· 60mg	$1.83/mg	+70.9%	—	1	94	Buy
	Welli Labs via Disclosed Labs · 1h ago	$540· 600mg	$0.90/mg	-16.1%	—	—	87	Buy
🇺🇸	Southern Aminos via Disclosed Labs · 1h ago	$56.00· 60mg	$0.93/mg	-13%	—	—	82	Buy Code MERIT · 15% off
🇺🇸	AMC Essentials ✓ verified at source · 1h ago	$49.99· 60mg	$0.83/mg	-22.3%	—	—	30	Buy affiliate

Cerebrolysin

Who's worth your money for Cerebrolysin

Watch Cerebrolysin

About Cerebrolysin

COAs for Cerebrolysin

20 citations indexed for Cerebrolysin

Very Early Short-Course Cerebrolysin After Tenecteplase and Mechanical Thrombectomy: A Case Report

Improvement of aphasia deficits following traumatic intracranial hemorrhage: a case report

Adjunctive Cerebrolysin therapy following mechanical thrombectomy for acute basilar artery occlusion: a case report

Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability

Cerebrolysin as an adjunct to speech-language therapy in post-stroke Wernicke's aphasia: a case report

Improvement of aphasia deficits following traumatic intracranial hemorrhage: a case report